Minimal Side Effects with New Class of Breast Cancer Drugs
New break throughs in hormonal therapy
Recently, hormonal therapies have been making major breakthroughs as a new type of oral drug becomes available as a treatment option. These new drugs are called cyclin-dependent kinase (CDK) inhibitors, and they are both effective and produce little to no side effects for most patients. The conclusion of a recent study on CDK inhibitors published in The Oncologist scientific journal reviews the new class of drugs and gives an overview to the successes and future promises of this important breakthrough.
